VIENNA–(BUSINESS WIRE)–Proxygen, a leader in the discovery and development of molecular glue degraders, announced today that the company has entered into a strategic multi-year research collaboration and license agreement with Merck. Proxygen is eligible to receive up to €495 million ($554 million at the average USD/EUR FX rate of Q1 2022) in continuous R&D funding, … [Read more…]
Healthcare technology company aims to pioneer the digital transformation of healthcare DALLAS–(BUSINESS WIRE)–After a rigorous agency selection process, Camelot Strategic Marketing & Media has been chosen as media buying and planning agency for healthcare technology company Cue Health (“Cue”) as it aims to pioneer the digital transformation of healthcare, beginning with diagnostics. The scope of … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Healthcare Analytics Market Size, Share & Industry Trends Analysis Report By Component, By Type, By End-user, By Deployment Model, By Application, By Regional Outlook and Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The Global Healthcare Analytics Market size is expected to reach $93.3 billion by 2027, rising at a market … [Read more…]
– Vertex announces three additional abstracts on the burden of beta thalassemia and sickle cell disease accepted for poster presentation – BOSTON & ZUG, Switzerland & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) today announced new late-breaking clinical data accepted for oral presentation at the 2022 European Hematology Association (EHA) … [Read more…]
The multi-center, pivotal DISTALS trial is enabled by TIGERTRIEVER™ 13, the smallest and only thrombectomy device designed for distal vessels YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–#DISTALS—Rapid Medical, a leading developer of advanced neurovascular devices, announced today the enrollment of the first patient in the DISTALS Study. The trial is the first-ever FDA investigational device exemption (IDE) … [Read more…]
SANTA FE, N.M.–(BUSINESS WIRE)–Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, today announced an agreement with the global healthcare company Sanofi under which Specifica’s patented Generation 3 Antibody Discovery Platform will be transferred to Sanofi. The comprehensive technology transfer package will enable the integration of Specifica’s … [Read more…]
Company’s web-based platform empowers researchers to integrate, process, and visualize biological data in one place, shortening timelines from experiment to results SAN FRANCISCO–(BUSINESS WIRE)–#AI–LatchBio, a company accelerating the pace of scientific progress by enabling researchers to store and analyze data without touching code or cloud infrastructure, today announced a $28 million Series A round co-led … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Additive Technology Markets for Engineered Solid Dosage Forms” report has been added to ResearchAndMarkets.com’s offering. 3D printing (3DP) or additive manufacturing (AM) is a family of technologies that implement layer-by-layer processes in order to fabricate physical models, based on a computer aided design (CAD) model. 3D printing permits the fabrication of high degrees … [Read more…]
mAbxience secures its second 4,000L ABEC Custom Single Run (CSR®) bioreactor to increase manufacturing capacity at its Leon, Spain facility BETHLEHEM, Pa.–(BUSINESS WIRE)–#ABEC—ABEC, a global provider of engineered solutions and services for biotech manufacturing, today announced that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an additional ABEC 4,000L CSR bioreactor. Following … [Read more…]
‘VecTabs’ developed using VectorY’s proprietary platform show positive effect on key drivers of ALS pathology AMSTERDAM–(BUSINESS WIRE)–VectorY, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of neurodegenerative and muscular disorders through vectorized antibodies, today announced new data at the 2022 ENCALS meeting in Edinburgh. The poster, which was … [Read more…]
